Literature DB >> 26201690

ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling.

L Koren1, D Alishekevitz2, O Elhanani1, A Nevelsky3, T Hai4, I Kehat5, Y Shaked2, A Aronheim6.   

Abstract

RATIONALE: Pressure overload induces adaptive remodeling processes in the heart. However, when pressure overload persists, adaptive changes turn into maladaptive alterations leading to cardiac hypertrophy and heart failure. ATF3 is a stress inducible transcription factor that is transiently expressed following neuroendocrine stimulation. However, its role in chronic pressure overload dependent cardiac hypertrophy is currently unknown.
OBJECTIVE: The objective of the study was to study the role of ATF3 in chronic pressure overload dependent cardiac remodeling processes. METHODS AND
RESULTS: Pressure overload was induced by phenylephrine (PE) mini-osmotic pumps in various mice models of whole body, cardiac specific, bone marrow (BM) specific and macrophage specific ATF3 ablations. We show that ATF3-KO mice exhibit a significantly reduced expression of cardiac remodeling markers following chronic pressure overload. Consistently, the lack of ATF3 specifically in either cardiomyocytes or BM derived cells blunts the hypertrophic response to PE infusion. A unique cross-talk between cardiomyocytes and macrophages was identified. Cardiomyocytes induce an ATF3 dependent induction of an inflammatory response leading to macrophage recruitment to the heart. Adoptive transfer of wild type macrophages, but not ATF3-KO derived macrophages, into wild type mice potentiates maladaptive response to PE infusion.
CONCLUSIONS: Collectively, this study places ATF3 as a key regulator in promoting pressure overload induced cardiac hypertrophy through a cross-talk between cardiomyocytes and macrophages. Inhibiting this cross-talk may serve as a useful approach to blunt maladaptive remodeling processes in the heart.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone marrow transplantation; Cardiac hypertrophy; Cardiac remodeling; Macrophages; Pressure overload

Mesh:

Substances:

Year:  2015        PMID: 26201690     DOI: 10.1016/j.ijcard.2015.06.099

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Molecular profiling of dilated cardiomyopathy that progresses to heart failure.

Authors:  Michael A Burke; Stephen Chang; Hiroko Wakimoto; Joshua M Gorham; David A Conner; Danos C Christodoulou; Michael G Parfenov; Steve R DePalma; Seda Eminaga; Tetsuo Konno; Jonathan G Seidman; Christine E Seidman
Journal:  JCI Insight       Date:  2016-05-05

2.  JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.

Authors:  Roy Kalfon; Tom Friedman; Shir Eliachar; Rona Shofti; Tali Haas; Lilach Koren; Jacob D Moskovitz; Tsonwin Hai; Ami Aronheim
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

3.  ATF3 expression in cardiomyocytes and myofibroblasts following transverse aortic constriction displays distinct phenotypes.

Authors:  Abu-Sharki Soraya; Haas Tali; Shofti Rona; Friedman Tom; Kalfon Roy; Aronheim Ami
Journal:  Int J Cardiol Heart Vasc       Date:  2020-12-29

Review 4.  The potential of using itaconate as treatment for inflammation-related heart diseases.

Authors:  Hui-Chen Ku; Ta-Chung Shen; Ching-Feng Cheng
Journal:  Tzu Chi Med J       Date:  2021-08-14

5.  The antiangiogenic role of the pro-inflammatory cytokine interleukin-31.

Authors:  Shiri Davidi; Ella Fremder; Tal Kan; Ziv Raviv; Michael Timaner; Nathan Karin; Dov Hershkovitz; Ami Arohneim; Yuval Shaked
Journal:  Oncotarget       Date:  2017-03-07

6.  JDP2 overexpression provokes cardiac dysfunction in mice.

Authors:  Jacqueline Heger; Julia Bornbaum; Alona Würfel; Christian Hill; Nils Brockmann; Renáta Gáspár; János Pálóczi; Zoltán V Varga; Márta Sárközy; Péter Bencsik; Tamás Csont; Szilvia Török; Baktybek Kojonazarov; Ralph Theo Schermuly; Kerstin Böngler; Mariana Parahuleva; Peter Ferdinandy; Rainer Schulz; Gerhild Euler
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.